Partner: Oxford Nanopore Technologies

Oxford Nanopore Technologies is a UK-based biotechnology company that develops and commercialises innovative nanopore DNA and RNA sequencing technologies, enabling rapid, real-time analysis of single molecules in formats ranging from portable, pocket-sized devices to high-throughput systems for large-scale genomics projects.

Founded in 2005 as a University of Oxford spin-out, the company’s platform, used in research, healthcare, environmental science, diagnostics and industrial applications across more than 120 countries, offers scalable sequencing solutions such as the handheld MinION, the bench-top GridION and the high-output PromethION, aimed at making advanced genetic analysis accessible, flexible and fast for scientists and organisations worldwide. Oxford Nanopore Technologies is publicly listed on the London Stock Exchange and headquartered at Oxford Science Park in the United Kingdom.